You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 10 Next »

Stock, concPreparation & Storage (Bennett Lab)Volumes, TubesLocation
10× T4 ligase bufferThawed, precipitates resuspended with vortexing/slight warming.50 µL aliquotsRack 1.5, -20°
10 mM dNTPs 20 µL aliquotsRack 1.5, -20°
Antibiotics
chl25 (mg/mL)Ethanol, -20° liquid; stable for ≥1 year.15 mLFreezer 1 door
amp10040% ethanol, -20° liquid; stable enough for ≥6 mo (8).
Definitely in water, -20° solid for ≥6 mo (10,11).
15 mLFreezer 1 door
kan50Water, 0° liquid; stable for ≥1 year.15 mLFreezer 0 door
spt50Water, 0° liquid; stable for ≥1 year.15 mLFreezer 0 door
gen10Water, -20° solid; stable for ≥1 year.~1 mLRack 1.5
str100Water, -20° solid; stable for ≥1 year.~1 mLRack 1.5, -20°
tet10Ethanol, -20° liquid; stable in dark for ≥1 year?~1 mLRack 1.5, -20°
zeo100?, -20° solid; stable in dark for ≥1 year.~1 mLRack 1.5, -20°

Antibiotics

 

 

AntibioticTarget Stock ConcentrationSolvents, TempNotesRich Medium
  Abbr*Relativem/V  c, Multi-Copy; Rangec, Single-CopyStability
Chloramphenicolribosomechl1000×

25 mg/mL

Ethanol, -20°(l) 25 or 34 mg/L (3)≥25–340 mg/L (5)10 mg/L (1)
or 5 mg/L (6)
All: ≥1 yr (8–10)
Ampicillin·Na
Carbenicillin·2Na
peptidoglycan

amp
car

1000×100 mg/mL40% ethanol, -20°(l)
or water, -20°(s)
40% EtOH keeps it liquid at -20°C. Substitutes carbenicillin.100 mg/L (3)≥100–200 mg/L50 mg/LStock: 6 mo with <¼ loss in water (10, 11).
Agar: selective for 4 mo (8), 44% loss every 4 mo (9).
Kanamycin A·SO4 ribosomekan1000×50 mg/mLWater, 0°(l); -20°(s)Insoluble in 40% ethanol. Precipitates in 35% DMSO.50 mg/L (3)≥50–500 mg/L (5)20 mg/L (1)All: ≥1 yr (8–10)
Spectinomycin·2HCl·5H2O ribosomespt1000×50 mg/mLWater, 0°(l); -20°(s)Precipitates in 35% DMSO. 50 mg/L (3)≥50–500 mg/L (5)20 mg/L (1)All: ≥1 yr (8–10)
Streptomycin·SO4ribosomestr1000×100 mg/mLWater, 0°(l); -20°(s).   All: ≥1 yr (8–10)
TrimethoprimFolA (DHFR)tmp1000×15 mg/mL

DMSO
1% acetic acid

Insoluble in water or ethanol.
Exogenous thymine can lead to evolution of resistance.
15 mg/L? 10 mg/L (2) 
Apramycin·SO4ribosomeapr1000×?Water.? ?All: ≥1 yr (8–10)
Gentamicin·SO4ribosomegen1000×10 mg/mL?Water.10 mg/L (8) 10 mg/L (1)All: ≥1 yr (8–10)
Erythromycinribosomeery   .    
Tetracycline·HClribosometet1000×10 mg/mLEthanolLight-sensitive.10 mg/L (3)10–15 mg/L15 mg/L (1)Stock: 4° ≤1 wk, -20° ≤2 mo (10)
Zeocin (Phleomycin D1·Cu2+)DNAzeo1000×25/100 mg/mLWaterUse 25 mg/L with LB-Lennox (5 g/L NaCl), pH 7.5.
Or use 100 mg/L for high-salt LB. Light-sensitive. Limit freeze-thaws.
25 mg/L (7, low-salt)
100 mg/L
25–50 mg/L (7, low-salt) Agar: 1 mo (Invivogen)
Hygromycin Bribosomehyg1000×200 mg/mLWater.200 mg/L (3)   

References

* Follow American Society of Microbiology AAC abbreviation guidelines when possible

  1. Poteete, Anthony R., Charles Rosadini, and Christine St. Pierre. "Gentamicin and other cassettes for chromosomal gene replacement in Escherichia coli.Biotechniques 41.3 (2006): 261-264.
  2. Kittleson, Joshua T., Sherine Cheung, and J Christopher Anderson. "Rapid optimization of gene dosage in E. coli using DIAL strains." Journal of biological engineering 5.1 (2011): 1-7.

  3. Addgene
  4. Qiagen
  5. Sara Molinari, unpublished data, p15A with cataphA1aadA.
  6. Addgene: Marionette Sensor Collection
  7. Zeocin | Thermo Fisher Scientific
  8. Bennett Lab experience, where antibiotics "working" means it kills lab E. coli in broth or agar sufficiently to not elicit concerns.
  9. Ryan, Kenneth J., et al. "Stability of antibiotics and chemotherapeutics in agar plates.Applied microbiology 20.3 (1970): 447-451.
  10. Berendsen, B. J. A., I. J. W. Elbers, and A. A. M. Stolker. "Determination of the stability of antibiotics in matrix and reference solutions using a straightforward procedure applying mass spectrometric detection.Food Additives & Contaminants: Part A 28.12 (2011): 1657-1666. Sci-Hub.
  11. Okerman, Lieve, Johan Van Hende, and Lieven De Zutter. "Stability of frozen stock solutions of beta-lactam antibiotics, cephalosporins, tetracyclines and quinolones used in antibiotic residue screening and antibiotic susceptibility testing.Analytica chimica acta 586.1-2 (2007): 284-288.

 

Lab Improvement Weekly: Investigative Report on Ampicillin. By Shyam Bhakta.

This week's investigative report examines everyone's favorite yet hated bacteriolytic antibiotic: ampicillin.

A 1990 paper¹ discusses how the secreted β-lactamase in a saturated preculture of an Ampᴿ strain can quickly consume all the ampicillin in a subculture. A stationary culture of ampicillin resistant cells can have such a concentration of β-lactamase that even a 1/200 – 1/1000 dilution will still contain enough β-lactamase to consume all the fresh ampicillin before all the non-resistant cells from the stationary phase culture have been killed. Even without any initial β-lactamase, enough β-lactamase is secreted quickly that toxic plasmids can quickly be lost midway through growth without facing selection. The authors recommend not allowing cultures to reach stationary phase if you need a high proportion of cells to contain your plasmid. And before subculturing, cells are best washed for Ampᴿ selection.

Ampicillin's bactericidal activity has a pH optimum is 5.5–6 and is tenfold less at pH 8 ³.

A paper on stability of antibiotics in solid medium over time ² found that 4 wk-old amp plates stored cold have a 30–50% loss in [amp] (causing a 10% change in zone of inhibition size), BUT no change (especially at our high concentration) that would dip below typical AmpS strain's MIC. Two-month-old plates would seem to be the limit, as after the resulting fourfold reduction in [amp] would approach the MIC. The rest of our common four antibiotics have no significant changes in agar over 2 months.

Activity reduction of a 100 mg/mL (1000×) aqueous, unbuffered solution of ampicillin³ ⁷:

         4°     20°  -20°

1 d: 15%, 28%

2 d: 33%, 45%

7 d: 65%, 81%

6 mo:              <10%

A number of studies have indicated that the stability of ampicillin in solution appears to be a function of pH, temperature, and even the identity of the buffer. Although ampicillin in any form is more readily soluble in base, it rapidly loses activity when stored above pH 7.0. ⁴ ⁵ ⁶ Optimal conditions for storage were suggested as 2–8°C, pH 3.8–5, retaining more than 90% activity for a week. Another review noted that the buffer used can also affect stability: at pH 7, Tris is "highly deleterious to the stability… but not so at pH 5;" citrate is fine at pH 7 but not at pH 5; acetate buffer seems best at pH 6.5 ⁵.

Carbenicillin is anecdotally more chemically stable in media, especially acidic and hot, and more resistant to β-lactamase, but I can only find published evidence that supports the former ⁸; I'm suspicious/doubt the latter claim. Maybe more carb survives 50° agar, but more amp (I've read 200 mg/L) can be used if it matters. While media stability ought to give carbenicillin an edge in selection against amp-sensitive mutants over long culture periods, especially in acidifying media (glucose carbon source), peptide broths like LB alkalify over culture time, and many-day culturing or a requirement of maintenance of 1× concentration in sterile media is rare. I've found 1× amp in LB30/TB liquid is selective for cloning for at least 2 wk in the fridge, longer for regular LB. The remaining amp only needs to exceed the MIC by a fewfold. 100–200 mg/L is 8–16-fold the MIC.

A new paper deletes a small part of the AmpR RBS so it makes less β-lactamase. Lowers how much amp is needed and it reduces β-lactamase accumulation to the level that subcultures of AmpR strains from amp to fresh amp medium preserves selection without quickly destroying all the amp ⁹.

¹ https://www.ncbi.nlm.nih.gov/pubmed/2199796?dopt=Abstract

² https://www.ncbi.nlm.nih.gov/pmc/articles/PMC376956/pdf/applmicro00107-0177.pdf

³ https://www.applichem.com/en/shop/product-detail/as/ampicillin-natriumsalz-ibiochemicai/

⁴ Analytical Profiles of Drug Substances, K. Florey, ed., (Academic Press, NY) Vol. 2, 1-61 (1973).

⁵ Gallelli, Amer. J. Hosp. Pharm., 24, 425-433 (1967)."Stability studies of drugs used in intravenous solutions, part one."

⁶ Lynn, B., Brit. J. Intravenous Therapy, 2, 22 (1981). "The stability and administration of intravenous penicillins."

⁷ https://www.sciencedirect.com/science/article/pii/S0003267006021076?via%3Dihub

⁸ https://sci-hub.tw/https://doi.org/10.1177/106002807000400802

⁹ https://doi.org/10.1021/acssynbio.1c00393

 

  • No labels